Mesalamine
NDC 31722-043, Mesalamine, tablet, delayed release, from Camber Pharmaceuticals, Inc..
- Product NDC
- 31722-043
- Status
- Listed
- Labeler
- Camber Pharmaceuticals, Inc.
- Dosage form
- TABLET, DELAYED RELEASE
- Route
- ORAL
- Product type
- HUMAN PRESCRIPTION DRUG
- Marketing category
- ANDA
- Application
- ANDA216334
- DEA schedule
- None
curl https://api.healthcare.dev/v1/drugs/ndc/31722-043 \ -H "Authorization: Bearer $HDEV_API_KEY"
Product
Active ingredients and packages
Active ingredients
- MESALAMINE1.2 g/1
Pharmacologic classes
Aminosalicylate [EPC]; Aminosalicylic Acids [CS]
| Package NDC | NDC-11 | Package |
|---|---|---|
| 31722-043-05 | 31722004305 | 500 TABLET, DELAYED RELEASE in 1 BOTTLE (31722-043-05) |
| 31722-043-12 | 31722004312 | 120 TABLET, DELAYED RELEASE in 1 BOTTLE (31722-043-12) |
Linked data
RxNorm, label and prices
RxNorm concepts
Related lookups
FDA label sections
GET /v1/drugs/labels/04ce2182-2e8c-4598-a269-550cfaddde6cNADAC price for package 31722004312
GET /v1/drugs/nadac/31722004312
Use it
Look up 31722-043 from code or an agent
curl https://api.healthcare.dev/v1/drugs/ndc/31722-043 \ -H "Authorization: Bearer $HDEV_API_KEY"
Using the healthcare.dev MCP server, look up NDC 31722-043. Tell me the product, its labeler, dosage form and route, its packages, and the RxNorm concepts it maps to.
Source: FDA, release 2026-10-23. Public domain. Reference data, not medical advice.